Group One Trading, L.P. Autolus Therapeutics PLC Transaction History

Group One Trading, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	SELL	$1.74 - $3.27 $5,568 - $10,464	-3,200 Reduced 54.24%	2,700 $5,000
Q2 2022 Aug 11, 2022	BUY	$2.04 - $4.68 $204 - $468	100 Added 1.72%	5,900 $17,000
Q1 2022 May 12, 2022	BUY	$3.52 - $5.46 $7,040 - $10,920	2,000 Added 52.63%	5,800 $24,000
Q4 2021 Feb 11, 2022	BUY	$5.1 - $7.0 $8,670 - $11,900	1,700 Added 80.95%	3,800 $20,000
Q3 2021 Nov 12, 2021	BUY	$5.32 - $7.37 $11,172 - $15,477	2,100 New	2,100 $14,000

104

163M

2.8K

13.4K

Ticker AUTL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 90,909,800
Market Cap $205M
Description
Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.